Human fetal and adult bone marrow-derived mesenchymal stem cells use different signaling pathways for the initiation of chondrogenesis

Stem Cells and Development

Volumn 23, Issue 5, 2014, Pages 541-554

  Brady, Kyla ^a   Dickinson, Sally C ^a   Guillot, Pascale V ^b   Polak, Julia ^b   Blom, Ashley W ^a   Kafienah, Wael ^a   Hollander, Anthony P ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELLS; BONE MARROW CELLS; CARTILAGE; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; HUMANS; MESENCHYMAL STROMAL CELLS; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA3;

EID: 84894315706     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0301     Document Type: Article

References (69)

1. Filardo G, H Madry, M Jelic, A Roffi, M Cucchiarini and E Kon. (2013). Mesenchymal stem cells for the treatment of cartilage lesions: From preclinical findings to clinical application in orthopaedics. Knee Surg Sports Traumatol Arthrosc 21:1717-1729.
2. Caplan AI. (2005). Review: Mesenchymal stem cells: Cellbased reconstructive therapy in orthopedics. Tissue Eng 11:1198-1211.
3. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
4. Johnstone B, TM Hering, AI Caplan, VM Goldberg and JU Yoo. (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238:265-272.
5. Kafienah W, S Mistry, SC Dickinson, TJ Sims, I Learmonth and AP Hollander. (2007). Three-dimensional cartilage tissue engineering using adult stem cells from osteoarthritis patients. Arthritis Rheum 56:177-187.
6. Macchiarini P, P Jungebluth, T Go, MA Asnaghi, LE Rees, TA Cogan, A Dodson, J Martorell, S Bellini, et al. (2008). Clinical transplantation of a tissue-engineered airway. Lancet 372:2023-2030.
7. Elliott MJ, P De Coppi, S Speggiorin, D Roebuck, CR Butler, E Samuel, C Crowley, C McLaren, A Fierens, et al. (2012). Stem-cell-based, tissue engineered tracheal replacement in a child: A 2-year follow-up study. Lancet 380:994-1000.
8. Pevsner-Fischer M, S Levin and D Zipori. (2011). The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev 7:560-568.
9. Bernardo ME, JA Emons, M Karperien, AJ Nauta, R Willemze, H Roelofs, S Romeo, A Marchini, GA Rappold, et al. (2007). Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connect Tissue Res 48:132-140.
10. Fehrer C and G Lepperdinger. (2005). Mesenchymal stem cell aging. Exp Gerontol 40:926-930.
11. Arufe MC, A De la Fuente, I Fuentes, FJ de Toro and FJ Blanco. (2010). Chondrogenic potential of subpopulations of cells expressing mesenchymal stem cell markers derived from human synovial membranes. J Cell Biochem 111:834-845.
12. Guillot PV, C Gotherstrom, J Chan, H Kurata and NM Fisk. (2007). Human first-Trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25:646-654.
13. Fong CY, K Gauthaman and A Bongso. (2010). Teratomas from pluripotent stem cells: A clinical hurdle. J Cell Biochem 111:769-781.
14. Blum B and N Benvenisty. (2008). The tumorigenicity of human embryonic stem cells. Adv Cancer Res 100:133-158.
15. Gotherstrom C, A West, J Liden, M Uzunel, R Lahesmaa and K Le Blanc. (2005). Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. Haematologica 90:1017-1026.
16. Guillot PV, C De Bari, F Dell'Accio, H Kurata, J Polak and NM Fisk. (2008). Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation 76:946-957.
17. Mirmalek-Sani SH, RS Tare, SM Morgan, HI Roach, DI Wilson, NA Hanley and RO Oreffo. (2006). Characterization and multipotentiality of human fetal femur-derived cells: Implications for skeletal tissue regeneration. Stem Cells 24:1042-1053.
18. Gotherstrom C, O Ringden, M Westgren, C Tammik and K Le Blanc. (2003). Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 32:265-272.
19. Campagnoli C, IA Roberts, S Kumar, PR Bennett, I Bellantuono and NM Fisk. (2001). Identification of mesenchymal stem/progenitor cells in human first-Trimester fetal blood, liver, and bone marrow. Blood 98:2396-2402.
20. Kolambkar YM, A Peister, S Soker, A Atala and RE Guldberg. (2007). Chondrogenic differentiation of amniotic fluidderived stem cells. J Mol Histol 38:405-413.
21. de Mara CS, AS Duarte, AR Sartori-Cintra, AC Luzo, ST Saad and IB Coimbra. (2012). Chondrogenesis from umbilical cord blood cells stimulated with BMP-2 and BMP-6. Rheumatol Int 33:121-128.
22. Mackay AM, SC Beck, JM Murphy, FP Barry, CO Chichester and MF Pittenger. (1998). Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4:415-428.
23. Wozney JM, V Rosen, AJ Celeste, LM Mitsock, MJ Whitters, RW Kriz, RM Hewick and EA Wang. (1988). Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534.
24. Wang EA, V Rosen, JS D'Alessandro, M Bauduy, P Cordes, T Harada, DI Israel, RM Hewick, KM Kerns, P LaPan, et al. (1990). Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 87:2220-2224.
25. Duprez DM, M Coltey, H Amthor, PM Brickell and C Tickle. (1996). Bone morphogenetic protein-2 (BMP-2) inhibits muscle development and promotes cartilage formation in chick limb bud cultures. Dev Biol 174:448-452.
26. Lyons KM, RW Pelton and BL Hogan. (1990). Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development 109:833-844.
27. Sekiya I, BL Larson, JT Vuoristo, RL Reger and DJ Prockop. (2005). Comparison of effect of BMP-2,-4, and-6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res 320:269-276.
28. Majumdar MK, E Wang and EA Morris. (2001). BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol 189:275-284.
29. Carlberg AL, B Pucci, R Rallapalli, RS Tuan and DJ Hall. (2001). Efficient chondrogenic differentiation of mesenchymal cells in micromass culture by retroviral gene transfer of BMP-2. Differentiation 67:128-138.
30. Schmitt B, J Ringe, T Haupl, M Notter, R Manz, GR Burmester, M Sittinger and C Kaps. (2003). BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture. Differentiation 71:567-577.
31. Indrawattana N, G Chen, M Tadokoro, LH Shann, H Ohgushi, T Tateishi, J Tanaka and A Bunyaratvej. (2004). Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochem Biophys Res Commun 320:914-919.
32. Ronziere MC, E Perrier, F Mallein-Gerin and AM Freyria. (2010). Chondrogenic potential of bone marrow-And adipose tissue-derived adult human mesenchymal stem cells. Biomed Mater Eng 20:145-158.
33. Sailor LZ, RM Hewick and EA Morris. (1996). Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-Term culture. J Orthop Res 14:937-945.
34. Wozney JM. (1989). Bone morphogenetic proteins. Prog Growth Factor Res 1:267-280.
35. Pizette S and L Niswander. (2000). BMPs are required at two steps of limb chondrogenesis: Formation of prechondrogenic condensations and their differentiation into chondrocytes. Dev Biol 219:237-249.
36. Oshin AO and MC Stewart. (2007). The role of bone morphogenetic proteins in articular cartilage development, homeostasis and repair. Vet Comp Orthop Traumatol 20: 151-158.
37. Blunk T, AL Sieminski, KJ Gooch, DL Courter, AP Hollander, AM Nahir, R Langer, G Vunjak-Novakovic and LE Freed. (2002). Differential effects of growth factors on tissueengineered cartilage. Tissue Eng 8:73-84.
38. Dickinson SC, TJ Sims, L Pittarello, C Soranzo, A Pavesio and AP Hollander. (2005). Quantitative outcome measures of cartilage repair in patients treated by tissue engineering. Tissue Eng 11:277-287.
39. Hollander AP, TF Heathfield, C Webber, Y Iwata, R Bourne, C Rorabeck and AR Poole. (1994). Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 93:1722-1732.
40. Handley CJ and DJ Buttle. (1995). Assay of proteoglycan degradation. Methods Enzymol 248:47-58.
41. Kafienah W, M Jakob, O Demarteau, A Frazer, MD Barker, I Martin and AP Hollander. (2002). Three-dimensional tissue engineering of hyaline cartilage: Comparison of adult nasal and articular chondrocytes. Tissue Eng 8:817-826.
42. in 't Anker PS, WA Noort, SA Scherjon, C Kleijburg-van der Keur, AB Kruisselbrink, RL van Bezooijen, W Beekhuizen, R Willemze, HH Kanhai and WE Fibbe. (2003). Mesenchymal stem cells in human second-Trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88:845-852.
43. Covas DT, RA Panepucci, AM Fontes, WA Silva, Jr., MD Orellana, MC Freitas, L Neder, AR Santos, LC Peres, MC Jamur andMAZago. (2008). Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146 + perivascular cells and fibroblasts. Exp Hematol 36:642-654.
44. Crisan M, S Yap, L Casteilla, CW Chen, M Corselli, TS Park, G Andriolo, B Sun, B Zheng, et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301-313.
45. Maijenburg MW, M Kleijer, K Vermeul, EP Mul, FP van Alphen, CE van der Schoot and C Voermans. (2012). The composition of the mesenchymal stromal cell compartment in human bone marrow changes during development and aging. Haematologica 97:179-183.
46. Guillot PV, O Abass, JH Bassett, SJ Shefelbine, G Bou-Gharios, J Chan, H Kurata, GR Williams, J Polak and NM Fisk. (2008). Intrauterine transplantation of human fetal mesenchymal stem cells from first-Trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 111:1717-1725.
47. Solchaga LA, K Penick, VM Goldberg, AI Caplan and JF Welter. (2010). Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A 16:1009-1019.
48. Shen B, A Wei, H Tao, AD Diwan and DD Ma. (2009). BMP-2 enhances TGF-beta3-mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture. Tissue Eng Part A 15:1311-1320.
49. Hennig T, H Lorenz, A Thiel, K Goetzke, A Dickhut, F Geiger and W Richter. (2007). Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 211:682-691.
50. Ng KK, HS Thatte and M Spector. (2011). Chondrogenic differentiation of adult mesenchymal stem cells and embryonic cells in collagen scaffolds. J Biomed Mater Res A 99:275-282.
51. Bai HY, GA Chen, GH Mao, TR Song and YX Wang. (2010). Three step derivation of cartilage like tissue from human embryonic stem cells by 2D-3D sequential culture in vitro and further implantation in vivo on alginate/PLGA scaffolds. J Biomed Mater Res A 94:539-546.
52. Massague J, J Seoane and D Wotton. (2005). Smad transcription factors. Genes Dev 19:2783-2810.
53. Itoh S, F Itoh, MJ Goumans and P Ten Dijke. (2000). Signaling of transforming growth factor-beta family members through Smad proteins. Eur J Biochem 267:6954-6967.
54. Furumatsu T, M Tsuda, N Taniguchi, Y Tajima and H Asahara. (2005). Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J Biol Chem 280:8343-8350.
55. Furumatsu T, M Tsuda, K Yoshida, N Taniguchi, T Ito, M Hashimoto and H Asahara. (2005). Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem 280:35203-35208.
56. Yang X, L Chen, X Xu, C Li, C Huang and CX Deng. (2001). TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 153:35-46.
57. Daly AC, RA Randall and CS Hill. (2008). Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol 28:6889-6902.
58. Goumans MJ, G Valdimarsdottir, S Itoh, A Rosendahl, P Sideras and P ten Dijke. (2002). Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21:1743-1753.
59. Goumans MJ, G Valdimarsdottir, S Itoh, F Lebrin, J Larsson, C Mummery, S Karlsson and P ten Dijke. (2003). Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12:817-828.
60. Gronroos E, IJ Kingston, A Ramachandran, RA Randall, P Vizan and CS Hill. (2012). Transforming growth factor beta inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes. Mol Cell Biol 32:2904-2916.
61. Hellingman CA, EN Davidson, W Koevoet, EL Vitters, WB Van Den Berg, GJ van Osch and PM van der Kraan. (2011). Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: Inhibition of Smad1/5/8P prevents terminal differentiation and calcification. Tissue Eng Part A 17:1157-1167.
62. Johansson N, U Saarialho-Kere, K Airola, R Herva, L Nissinen, J Westermarck, E Vuorio, J Heino and VM Kahari. (1997). Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 208:387-397.
63. Blaney Davidson EN, DF Remst, EL Vitters, HM van Beuningen, AB Blom, MJ Goumans, WB Van Den Berg and PM van der Kraan. (2009). Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol 182:7937-7945.
64. Chen-An P, KV Andreassen, K Henriksen, MA Karsdal and AC Bay-Jensen. (2013). Investigation of chondrocyte hypertrophy and cartilage calcification in a full-depth articular cartilage explants model. Rheumatol Int 33:401-411.
65. Pelttari K, A Winter, E Steck, K Goetzke, T Hennig, BG Ochs, T Aigner and W Richter. (2006). Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 54:3254-3266.
66. Steinert AF, B Proffen, M Kunz, C Hendrich, SC Ghivizzani, U Noth, A Rethwilm, J Eulert and CH Evans. (2009). Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther 11:R148.
67. Partridge K, X Yang, NM Clarke, Y Okubo, K Bessho, W Sebald, SM Howdle, KM Shakesheff and RO Oreffo. (2002). Adenoviral BMP-2 gene transfer in mesenchymal stem cells: In vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun 292:144-152.
68. Jeong CG, H Zhang and SJ Hollister. (2012). Three-dimensional polycaprolactone scaffold-conjugated bone morphogenetic protein-2 promotes cartilage regeneration from primary chondrocytes in vitro and in vivo without accelerated endochondral ossification. J Biomed Mater Res A 100:2088-2096.
69. Applegate LA, C Scaletta, N Hirt-Burri, W Raffoul and D Pioletti. (2009). Whole-cell bioprocessing of human fetal cells for tissue engineering of skin. Skin Pharmacol Physiol 22:63-73.